GE HealthCare Technologies (GEHC)
搜索文档
Here's Why GE HealthCare Technologies (GEHC) is a Strong Momentum Stock
Zacks Investment Research· 2024-02-20 23:50
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium also includes the Zacks Style Scores. ...
Serving Patients and Communities Through Comprehensive Care Solutions: OSF HealthCare, Pointcore, Inc. and GE HealthCare Enter Strategic Care Alliance
Businesswire· 2024-02-19 23:00
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced a collaboration with OSF HealthCare, an integrated health system caring for patients throughout Illinois and Michigan, and Pointcore, Inc., a healthcare management and non-clinical shared services company, to help increase clinical and operational efficiencies, standardize care delivery models and improve patient outcomes across OSF HealthCare. This alliance will leverage GE HealthCare’s expertise and innovative technology and Pointcore’ ...
GE HealthCare Technologies Inc. Prices Secondary Offering of 13,000,000 Shares
Businesswire· 2024-02-16 13:47
GE HealthCare Technologies Inc.次级公开发行 - GE HealthCare Technologies Inc.宣布定价之前宣布的13,000,000股普通股次级公开发行[1] - General Electric Company预计将GEHC股票与Morgan Stanley Senior Funding, Inc.和Morgan Stanley Bank, N.A.持有的GE债务进行交换[2] - Morgan Stanley、BofA Securities、Citigroup、Evercore ISI、Goldman Sachs & Co. LLC和J.P. Morgan担任Offering的主要联席主承销商[4]
GE HealthCare Technologies Inc. Commences Secondary Offering of 13,000,000 Shares
Businesswire· 2024-02-16 05:55
CHICAGO--(BUSINESS WIRE)--GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the launch of a secondary underwritten public offering (the “Offering”) of 13,000,000 shares of its common stock (the “GEHC Shares”). GE HealthCare is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the Offering or from the debt-for-equity exchange (as described below). Prior to the closing of the Offering, General Electric ...
Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term
Zacks Investment Research· 2024-02-14 23:41
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores.What are t ...
Why GE HealthCare Technologies (GEHC) is a Top Stock for the Long-Term
Zacks Investment Research· 2024-02-14 23:31
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.One of our most popular services, Zacks Premium offers daily updates of the Zacks Rank and Zacks Industry Rank; full access to the Zacks #1 Rank List; Equity Research reports; and Premium stock screens like the Earnings ESP filter. All are useful tools to find what stocks to buy, what to sell, and what are today's hottest industries.It a ...
GE Healthcare (GEHC), MedQuest Partner to Boost Imaging Field
Zacks Investment Research· 2024-02-14 00:55
GE Healthcare与MedQuest Associates合作 - GE Healthcare与MedQuest Associates宣布合作,以提升多地点门诊影像网络[1] - GE Healthcare和MedQuest的合作旨在优化影像解决方案,支持Theranostics[2] - 合作旨在通过创新技术提升门诊影像解决方案,提高运营效率和患者护理质量[4] - GE Healthcare的突破性技术与MedQuest的协作模式将推动发展中的影像解决方案进入门诊环境[5] - GE Healthcare的AI数字能力将帮助MedQuest扩展门诊影像空间的高效护理能力[6] 市场趋势和预测 - GEHC股价过去六个月上涨15.8%,行业下跌0.9%,标普500指数同期增长11.8%[3] - 全球诊断影像服务市场预计到2027年将达到7026亿美元,增长率为5.1%[9] - 高慢性疾病和老年患者人口增加,不同影像程序意识提高,新影像诊断中心快速扩张推动市场增长[10] 公司股票表现 - GEHC目前持有Zacks Rank 3 (Hold)[11] - 在更广泛的医疗领域,一些排名更高的股票包括Universal Health Services (UHS), Integer Holdings Corporation (ITGR)和Elevance Health, Inc (ELV)[12] - UHS的股价过去六个月上涨1.9%,ITGR的股价过去一年上涨43.5%,ELV的长期预期增长率为12%[13] - ITGR过去四个季度的盈利超过预期,平均超出11.9%[14] - ELV过去四个季度的盈利也超出预期,平均超出3.1%[15]
GE HealthCare and MedQuest Associates Collaborate to Provide Innovative Medical Device Technology and Digital Tools for Outpatient Imaging Centers
Businesswire· 2024-02-08 23:00
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and MedQuest Associates (MedQuest), a leading owner, operator, and manager of outpatient diagnostic imaging facilities, today announced a three-year collaboration to deliver excellence in patient care by providing access to innovative technologies from GE HealthCare and the infrastructure and resources from MedQuest that are needed to optimize multi-site o ...
S&P 500 Gains and Losses Today: GE HealthCare Shares Soar After Strong Earnings
Investopedia· 2024-02-07 06:10
S&P 500指数 - 美国标准普尔500指数(S&P 500)在2024年2月6日周二上涨了0.2%[1] GE HealthCare - 通用电气医疗保健(GE HealthCare)股价飙升,因为成像和患者护理解决方案的增长帮助推动了强劲的收益[2] FMC公司 - FMC公司股价暴跌,因为农业公司提供了乏善可陈的指引,反映了低销售量和库存问题的影响[3] - FMC公司的股价在S&P 500股票中跌幅最大,下跌了11.5%[9] 杜邦公司 - 杜邦公司(DuPont de Nemours)的季度业绩也表现强劲,股价上涨了7.4%[7] Willis Towers Watson - 保险公司Willis Towers Watson的业绩也强劲,股价上涨了7.2%[8] Charter Communications - Charter Communications股价下跌了4.4%,分析师下调了该公司的股票评级[10] Tyson食品公司 - Tyson食品公司的股价下跌了3.7%,尽管该公司季度利润超出预期,但需求前景仍不确定[11]
GE HealthCare (GEHC) Q4 Earnings Beat, Volume & Price Improve
Zacks Investment Research· 2024-02-07 03:31
第四季度财报 - GE HealthCare (GEHC)报告2023年第四季度调整后每股收益为1.18美元,超出Zacks共识预期10.3%[1] - 公司第四季度总收入为52亿美元,同比增长5%,超出Zacks共识预期2.2%[2] - GEHC第四季度现金及等价物和投资为25亿美元,较上一季度增加0.09亿美元[9] 各部门收入情况 - 影像部门收入为28亿美元,同比增长4%[3] - 超声波部门收入为9.44亿美元,同比下降1%[4] - 患者护理解决方案部门收入为8.27亿美元,同比增长5%[5] - 制药诊断部门收入为1.44亿美元,同比增长25%[6] 公司整体情况 - 公司2023年总收入为196亿美元,同比增长7%[8] - 公司在2024年预计调整后每股收益为4.20-4.35美元,销售额有望有机增长4%[12]